FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3166340770> ?p ?o ?g. }

• W3166340770 abstract "Previous analysis of the study (NCT02577393) had demonstrated the application of epigallocatechin-3-gallate (EGCG) could be safe and effective in the prevention and treatment of acute radiation esophagitis in patients with advanced lung cancer. EGCG seemed to improve the response rate of small cell lung cancer (SCLC) to radiotherapy in a subgroup analysis. This research continued to analyze the impact of EGCG application on cancer-radiation efficacy and patient survival.All patients with SCLC in the NCT02577393 study were included. Patients were randomized into EGCG group or conventional therapy group as protocol. The primary endpoints of the study were radiation response rate and progression-free survival (PFS). Overall survival (OS) and the efficacy of EGCG in the treatment of esophagitis were assessed as secondary endpoints.A total of 83 patients with lung cancer in the NCT02577393 study were screened, and all 38 patients with SCLC were eligible for analysis. No significant differences with regard to baseline demographic and clinical characteristics were observed between the two groups. The objective response rate (ORR) was higher than that of conventionally treated patients (84.6 vs 50%, P = 0.045), while the median PFS and OS were not significantly prolonged. At data cut-off (1 January 2021), 5-year PFS was 33% with EGCG versus 9.3% with conventional treatment, and 5-year OS was 30.3% versus 33.3%, respectively. The mean adjusted esophagitis index and pain index of patients with EGCG application were lower than conventional treatment (5.15 ± 2.75 vs 7.17 ± 1.99, P = 0.030; 8.62 ± 5.04 vs 15.42 ± 5.04, P < 0.001).The study indicates EGCG may alleviate some esophagitis-related indexes in SCLC patients exposed to ionizing radiation without reducing survival. However, this conclusion should be confirmed by further studies with large sample size." @default.
• W3166340770 created "2021-06-22" @default.
• W3166340770 creator A5001774854 @default.
• W3166340770 creator A5014475786 @default.
• W3166340770 creator A5015950934 @default.
• W3166340770 creator A5017401077 @default.
• W3166340770 creator A5022526821 @default.
• W3166340770 creator A5045388585 @default.
• W3166340770 creator A5087455824 @default.
• W3166340770 date "2021-06-10" @default.
• W3166340770 modified "2023-10-18" @default.
• W3166340770 title "Evaluation of Epigallocatechin-3-Gallate as a Radioprotective Agent During Radiotherapy of Lung Cancer Patients: A 5-Year Survival Analysis of a Phase 2 Study" @default.
• W3166340770 cites W1981332357 @default.
• W3166340770 cites W2005377226 @default.
• W3166340770 cites W2022948875 @default.
• W3166340770 cites W2035119888 @default.
• W3166340770 cites W2106860587 @default.
• W3166340770 cites W2114843297 @default.
• W3166340770 cites W2119709711 @default.
• W3166340770 cites W2123884399 @default.
• W3166340770 cites W2134576402 @default.
• W3166340770 cites W2147800503 @default.
• W3166340770 cites W2167099568 @default.
• W3166340770 cites W2178725095 @default.
• W3166340770 cites W2263602090 @default.
• W3166340770 cites W2407762703 @default.
• W3166340770 cites W2612390378 @default.
• W3166340770 cites W2767354614 @default.
• W3166340770 cites W2859647256 @default.
• W3166340770 cites W2888393680 @default.
• W3166340770 cites W2898474242 @default.
• W3166340770 cites W2902806889 @default.
• W3166340770 cites W2918983027 @default.
• W3166340770 cites W2922795117 @default.
• W3166340770 cites W2961319233 @default.
• W3166340770 cites W2962012123 @default.
• W3166340770 cites W2971414624 @default.
• W3166340770 cites W2974853900 @default.
• W3166340770 cites W2984779753 @default.
• W3166340770 cites W2991359960 @default.
• W3166340770 cites W2994763742 @default.
• W3166340770 cites W2996734517 @default.
• W3166340770 cites W2998465014 @default.
• W3166340770 cites W3012661873 @default.
• W3166340770 cites W3013922958 @default.
• W3166340770 cites W3028928095 @default.
• W3166340770 cites W3039476842 @default.
• W3166340770 cites W3041174988 @default.
• W3166340770 cites W3042800031 @default.
• W3166340770 cites W3092890104 @default.
• W3166340770 cites W4254015501 @default.
• W3166340770 cites W4300549900 @default.
• W3166340770 doi "https://doi.org/10.3389/fonc.2021.686950" @default.
• W3166340770 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8223749" @default.
• W3166340770 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34178681" @default.
• W3166340770 hasPublicationYear "2021" @default.
• W3166340770 type Work @default.
• W3166340770 sameAs 3166340770 @default.
• W3166340770 citedByCount "4" @default.
• W3166340770 countsByYear W31663407702022 @default.
• W3166340770 countsByYear W31663407702023 @default.
• W3166340770 crossrefType "journal-article" @default.
• W3166340770 hasAuthorship W3166340770A5001774854 @default.
• W3166340770 hasAuthorship W3166340770A5014475786 @default.
• W3166340770 hasAuthorship W3166340770A5015950934 @default.
• W3166340770 hasAuthorship W3166340770A5017401077 @default.
• W3166340770 hasAuthorship W3166340770A5022526821 @default.
• W3166340770 hasAuthorship W3166340770A5045388585 @default.
• W3166340770 hasAuthorship W3166340770A5087455824 @default.
• W3166340770 hasBestOaLocation W31663407701 @default.
• W3166340770 hasConcept C121608353 @default.
• W3166340770 hasConcept C126322002 @default.
• W3166340770 hasConcept C143998085 @default.
• W3166340770 hasConcept C168563851 @default.
• W3166340770 hasConcept C185592680 @default.
• W3166340770 hasConcept C203092338 @default.
• W3166340770 hasConcept C2776256026 @default.
• W3166340770 hasConcept C2777192995 @default.
• W3166340770 hasConcept C2778004101 @default.
• W3166340770 hasConcept C2779134260 @default.
• W3166340770 hasConcept C2779920096 @default.
• W3166340770 hasConcept C43270747 @default.
• W3166340770 hasConcept C509974204 @default.
• W3166340770 hasConcept C55493867 @default.
• W3166340770 hasConcept C70899900 @default.
• W3166340770 hasConcept C71924100 @default.
• W3166340770 hasConcept C90924648 @default.
• W3166340770 hasConceptScore W3166340770C121608353 @default.
• W3166340770 hasConceptScore W3166340770C126322002 @default.
• W3166340770 hasConceptScore W3166340770C143998085 @default.
• W3166340770 hasConceptScore W3166340770C168563851 @default.
• W3166340770 hasConceptScore W3166340770C185592680 @default.
• W3166340770 hasConceptScore W3166340770C203092338 @default.
• W3166340770 hasConceptScore W3166340770C2776256026 @default.
• W3166340770 hasConceptScore W3166340770C2777192995 @default.
• W3166340770 hasConceptScore W3166340770C2778004101 @default.
• W3166340770 hasConceptScore W3166340770C2779134260 @default.
• W3166340770 hasConceptScore W3166340770C2779920096 @default.
• W3166340770 hasConceptScore W3166340770C43270747 @default.
• W3166340770 hasConceptScore W3166340770C509974204 @default.

• next